Correlation Between Surrozen and SAB Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Surrozen and SAB Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Surrozen and SAB Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Surrozen and SAB Biotherapeutics, you can compare the effects of market volatilities on Surrozen and SAB Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Surrozen with a short position of SAB Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Surrozen and SAB Biotherapeutics.
Diversification Opportunities for Surrozen and SAB Biotherapeutics
0.22 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Surrozen and SAB is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding Surrozen and SAB Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SAB Biotherapeutics and Surrozen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Surrozen are associated (or correlated) with SAB Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SAB Biotherapeutics has no effect on the direction of Surrozen i.e., Surrozen and SAB Biotherapeutics go up and down completely randomly.
Pair Corralation between Surrozen and SAB Biotherapeutics
Given the investment horizon of 90 days Surrozen is expected to generate 0.6 times more return on investment than SAB Biotherapeutics. However, Surrozen is 1.67 times less risky than SAB Biotherapeutics. It trades about -0.07 of its potential returns per unit of risk. SAB Biotherapeutics is currently generating about -0.12 per unit of risk. If you would invest 1,435 in Surrozen on November 1, 2024 and sell it today you would lose (228.00) from holding Surrozen or give up 15.89% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Surrozen vs. SAB Biotherapeutics
Performance |
| Timeline |
| Surrozen |
| SAB Biotherapeutics |
Surrozen and SAB Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Surrozen and SAB Biotherapeutics
The main advantage of trading using opposite Surrozen and SAB Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Surrozen position performs unexpectedly, SAB Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SAB Biotherapeutics will offset losses from the drop in SAB Biotherapeutics' long position.| Surrozen vs. Bolt Biotherapeutics | Surrozen vs. Larimar Therapeutics | Surrozen vs. Keros Therapeutics | Surrozen vs. Kezar Life Sciences |
| SAB Biotherapeutics vs. Processa Pharmaceuticals | SAB Biotherapeutics vs. Third Harmonic Bio | SAB Biotherapeutics vs. Cingulate Warrants | SAB Biotherapeutics vs. Anebulo Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |